+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Small Molecule, Biologics), Drug, Service, Scale of Operation, Workflow, Application, End Use, Company, and Region with Growth Forecasts, 2025-2030- Product Image
Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Small Molecule, Biologics), Drug, Service, Scale of Operation, Workflow, Application, End Use, Company, and Region with Growth Forecasts, 2025-2030- Product Image
New

Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Small Molecule, Biologics), Drug, Service, Scale of Operation, Workflow, Application, End Use, Company, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 6056000
Description Jump to:
The Pharmaceutical Contract Manufacturing Market was valued at USD 129.19 billion in 2024, and is projected to reach USD 224.51 billion by 2030, rising at a CAGR of 9.84%. The market is anticipated to grow at a CAGR of 9.84% from 2025 to 2030. Growth in the market can be attributed to benefits offered to pharmaceutical companies, such as cost efficiencies, the ability to leverage contract manufacturing facilities to streamline production, and the opportunity to focus on core competencies. In addition, the market is driven by the increasing demand for biologics, biosimilars, high-potency active pharmaceutical ingredients (HPAPIs), and personalized medicine.

The expansion of pharmaceutical companies into new product innovations has led to the increased demand for contract manufacturing organization (CMO) services for clinical trials, packaging, and regulatory compliance. Technological integrations among CMOs, such as continuous manufacturing, automation, and AI-driven process optimization, are further propelling pharmaceutical production. These innovations enhance efficiency, reduce waste, and improve product quality and standards.

The pharmaceutical contract manufacturing industry is expected to experience continued growth during the forecast period, as CMO providers play a crucial role in helping companies meet the regulatory requirements of the FDA, EMA, and ICH. Moreover, the growing demand for both branded and generic drugs is a significant factor in the expansion of the pharmaceutical contract manufacturing industry. As various generic drugs reach patent expiration, pharmaceutical companies are innovating new generic versions to meet this demand. Hence, many of these pharmaceutical companies are relying on CMO services to fulfill market needs efficiently and effectively.

In addition, regulation is one of the significant factors for pharmaceutical products that have fueled the demand for pharmaceutical contract manufacturing. The FDA plays a pivotal role in ensuring the safety and efficiency of pharmaceuticals in the market. Likewise, strategic partnerships and accelerating product launches drive market growth. For instance, in December 2024, Lonza mentioned the expansion of its service offering orally delivered biologic therapies to support innovative capsule companies' unique development and manufacturing needs. The product launch will help patients explore innovative delivery solutions to mitigate bioavailability challenges.

Pharmaceutical Contract Manufacturing Market Report Highlights

  • The API manufacturing segment dominated the market with a share of 70.68% in 2024. Growth in the segment can be attributed to increasing HPAPI production, rising demand for continuous API manufacturing, growing FDA approval for the market, and the launch of new products.
  • Based on product, the small molecule segment held the largest market share in 2024, which is attributed to the increasing demand for generics, specialty drugs, and HPAPIs, and growing innovations of drugs have enhanced the requirement for CMO’s efficiency, scalability, and regulatory compliance further driving the market growth.
  • The generics segment dominated the market in 2024 owing to the increasing prevalence of chronic diseases, growing patent expirations, and rising demand for cost-efficient drugs.
  • Based on scale of operation, the batch segment dominated the market. It accounted for 88.88% in 2024, attributing to various benefits such as batch production and major support for saving operational costs.
  • The commercial segment dominated the market in 2024. Growth in this segment can be attributed to the increasing launch of various products that help treat diseases.
  • The oncology segment held the largest market share in 2024 based on application. This segment is driven by increasing cancer incidences and new pharmaceutical drug requirements.
  • The pharmaceutical companies segment held the largest market share in 2024 based on end-use. Pharmaceutical companies utilize contract manufacturing to lower costs, increase scalability, and speed up time-to-market. CMOs offer expertise in API synthesis, formulation, and regulatory compliance. In addition, outsourcing provides access to advanced technologies, flexible production capacity, and optimized global supply chains.
  • The small company size segment dominated the market in 2024 due to increasing employee strengths, facilities, and venture funding.
  • Asia Pacific is expected to register the fastest growth rate of 10.80% CAGR over the forecast period. Due to the rising number of pharmaceutical companies & contract manufacturing organizations in countries like Japan, China, and India, Asia Pacific will likely witness rapid growth over the estimated time. Furthermore, the availability of a skilled workforce within the region at a lower cost compared to the U.S. is another factor that is anticipated to propel the market growth.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. Product
1.2.3. Drug
1.2.4. Scale of Operation
1.2.5. Workflow
1.2.6. Application
1.2.7. End Use
1.2.8. Company Size
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights
Chapter 3. Pharmaceutical Contract Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Technological Advancements
3.4. Clinical trials volume analysis (2024)
3.5. Pharmaceutical Contract Manufacturing Market Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Analysis
3.5.2. PESTEL Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Pharmaceutical Contract Manufacturing Market: Service Estimates & Trend Analysis
4.1. Pharmaceutical Contract Manufacturing Market, by Service: Segment Dashboard
4.2. Pharmaceutical Contract Manufacturing Market, by Service: Movement Analysis
4.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Service, 2018-2030
4.4. API Manufacturing
4.4.1. API Manufacturing Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Finished Drug Product Manufacturing
4.5.1. Finished Drug Product Manufacturing Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.2. Oral Solids
4.5.2.1. Oral Solids Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.3. Liquids
4.5.3.1. Liquids Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.4. Topical
4.5.4.1. Topical Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.5. Others
4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Packaging Services
4.6.1. Packaging Services Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Pharmaceutical Contract Manufacturing Market: Product Estimates & Trend Analysis
5.1. Pharmaceutical Contract Manufacturing Market, by Product: Segment Dashboard
5.2. Pharmaceutical Contract Manufacturing Market, by Product: Movement Analysis
5.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Product, 2018-2030
5.4. Small Molecule
5.4.1. Small Molecule Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Biologics
5.5.1. Biologics Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5.2. Monoclonal Antibodies
5.5.2.1. Monoclonal Antibodies Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5.3. Vaccines
5.5.3.1. Vaccines Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5.4. Recombinant Proteins
5.5.4.1. Recombinant Proteins Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5.5. Others
5.5.5.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Pharmaceutical Contract Manufacturing Market: Drug Estimates & Trend Analysis
6.1. Pharmaceutical Contract Manufacturing Market, by Drug: Segment Dashboard
6.2. Pharmaceutical Contract Manufacturing Market, by Drug: Movement Analysis
6.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Drug, 2018-2030
6.4. Generics
6.4.1. Generics Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Branded
6.5.1. Branded Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Pharmaceutical Contract Manufacturing Market: Scale of Operation Estimates & Trend Analysis
7.1. Pharmaceutical Contract Manufacturing Market, by Scale of Operation: Segment Dashboard
7.2. Pharmaceutical Contract Manufacturing Market, by Scale of Operation: Movement Analysis
7.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Scale of Operation, 2018-2030
7.4. Batch
7.4.1. Batch Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Continuous
7.5.1. Continuous Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Pharmaceutical Contract Manufacturing Market: Workflow Estimates & Trend Analysis
8.1. Pharmaceutical Contract Manufacturing Market, by Workflow: Segment Dashboard
8.2. Pharmaceutical Contract Manufacturing Market, by Workflow: Movement Analysis
8.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Workflow, 2018-2030
8.4. Clinical
8.4.1. Clinical Market, 2018 to 2030, (USD Million)
8.5. Commercial
8.5.1. Commercial Market, 2018 to 2030, (USD Million)
Chapter 9. Pharmaceutical Contract Manufacturing Market: Application Estimates & Trend Analysis
9.1. Pharmaceutical Contract Manufacturing Market, by Application: Segment Dashboard
9.2. Pharmaceutical Contract Manufacturing Market, by Application: Movement Analysis
9.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Application, 2018-2030
9.4. Oncology
9.4.1. Oncology Market, 2018 to 2030, (USD Million)
9.5. Infectious Diseases
9.5.1. Infectious Diseases Market, 2018 to 2030, (USD Million)
9.6. Neurological Disorders
9.6.1. Neurological Disorders Market, 2018 to 2030, (USD Million)
9.7. Cardiovascular Disease
9.7.1. Cardiovascular Disease Market, 2018 to 2030, (USD Million)
9.8. Metabolic Disorders
9.8.1. Metabolic Disorders Market, 2018 to 2030, (USD Million)
9.9. Autoimmune Diseases
9.9.1. Autoimmune Diseases Market, 2018 to 2030, (USD Million)
9.10. Respiratory Diseases
9.10.1. Respiratory Diseases Market, 2018 to 2030, (USD Million)
9.11. Ophthalmology
9.11.1. Ophthalmology Market, 2018 to 2030, (USD Million)
9.12. Gastrointestinal Disorders
9.12.1. Gastrointestinal Disorders Market, 2018 to 2030, (USD Million)
9.13. Hormonal Disorders
9.13.1. Hormonal Disorders Market, 2018 to 2030, (USD Million)
9.14. Hematological Disorders
9.14.1. Hematological Disorders Market, 2018 to 2030, (USD Million)
9.15. Others
9.15.1. Others Market, 2018 to 2030, (USD Million)
Chapter 10. Pharmaceutical Contract Manufacturing Market: End Use Estimates & Trend Analysis
10.1. Pharmaceutical Contract Manufacturing Market, by End Use: Segment Dashboard
10.2. Pharmaceutical Contract Manufacturing Market, by End Use: Movement Analysis
10.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by End Use, 2018-2030
10.4. Pharmaceutical Companies
10.4.1. Pharmaceutical Companies Market, 2018 to 2030, (USD Million)
10.5. Biotechnology Companies
10.5.1. Biotechnology Companies Market, 2018 to 2030, (USD Million)
Chapter 11. Pharmaceutical Contract Manufacturing Market: Company Size Estimates & Trend Analysis
11.1. Pharmaceutical Contract Manufacturing Market, by Company Size: Segment Dashboard
11.2. Pharmaceutical Contract Manufacturing Market, by Company Size: Movement Analysis
11.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Company Size, 2018-2030
11.4. Small
11.4.1. Small Market, 2018 to 2030, (USD Million)
11.5. Medium
11.5.1. Medium Market, 2018 to 2030, (USD Million)
11.6. Large
11.6.1. Large Market, 2018 to 2030, (USD Million)
Chapter 12. Pharmaceutical Contract Manufacturing Market: Regional Estimates & Trend Analysis
12.1. Regional Market Share Analysis, 2024 & 2030
12.2. Regional Market Dashboard
12.3. Global Regional Market Snapshot
12.4. North America
12.4.1. North America Market Estimates and Forecasts, 2018-2030 (USD Million)
12.4.2. U.S
12.4.2.1. Key Country Dynamics
12.4.2.2. Competitive Scenario
12.4.2.3. Regulatory Framework
12.4.2.4. U.S. Market Estimates and Forecasts, 2018-2030 (USD Million)
12.4.3. Canada
12.4.3.1. Key Country Dynamics
12.4.3.2. Competitive Scenario
12.4.3.3. Regulatory Framework
12.4.3.4. Canada Market Estimates and Forecasts, 2018-2030 (USD Million)
12.4.4. Mexico
12.4.4.1. Key Country Dynamics
12.4.4.2. Competitive Scenario
12.4.4.3. Regulatory Framework
12.4.4.4. Mexico Market Estimates and Forecasts, 2018-2030 (USD Million)
12.5. Europe
12.5.1. Europe Market Estimates and Forecasts, 2018-2030 (USD Million)
12.5.2. UK
12.5.2.1. Key Country Dynamics
12.5.2.2. Competitive Scenario
12.5.2.3. Regulatory Framework
12.5.2.4. UK Market Estimates and Forecasts, 2018-2030 (USD Million)
12.5.3. Germany
12.5.3.1. Key Country Dynamics
12.5.3.2. Competitive Scenario
12.5.3.3. Regulatory Framework
12.5.3.4. Germany Market Estimates and Forecasts, 2018-2030 (USD Million)
12.5.4. France
12.5.4.1. Key Country Dynamics
12.5.4.2. Competitive Scenario
12.5.4.3. Regulatory Framework
12.5.4.4. France Market Estimates and Forecasts, 2018-2030 (USD Million)
12.5.5. Italy
12.5.5.1. Key Country Dynamics
12.5.5.2. Competitive Scenario
12.5.5.3. Regulatory Framework
12.5.5.4. Italy Market Estimates and Forecasts, 2018-2030 (USD Million)
12.5.6. Spain
12.5.6.1. Key Country Dynamics
12.5.6.2. Competitive Scenario
12.5.6.3. Regulatory Framework
12.5.6.4. Spain Market Estimates and Forecasts, 2018-2030 (USD Million)
12.5.7. Denmark
12.5.7.1. Key Country Dynamics
12.5.7.2. Competitive Scenario
12.5.7.3. Regulatory Framework
12.5.7.4. Denmark Market Estimates and Forecasts, 2018-2030 (USD Million)
12.5.8. Sweden
12.5.8.1. Key Country Dynamics
12.5.8.2. Competitive Scenario
12.5.8.3. Regulatory Framework
12.5.8.4. Sweden Market Estimates and Forecasts, 2018-2030 (USD Million)
12.5.9. Norway
12.5.9.1. Key Country Dynamics
12.5.9.2. Competitive Scenario
12.5.9.3. Regulatory Framework
12.5.9.4. Norway Market Estimates and Forecasts, 2018-2030 (USD Million)
12.6. Asia Pacific
12.6.1. Asia Pacific Market Estimates and Forecasts, 2018-2030 (USD Million)
12.6.2. Japan
12.6.2.1. Key Country Dynamics
12.6.2.2. Competitive Scenario
12.6.2.3. Regulatory Framework
12.6.2.4. Japan Market Estimates and Forecasts, 2018-2030 (USD Million)
12.6.3. China
12.6.3.1. Key Country Dynamics
12.6.3.2. Competitive Scenario
12.6.3.3. Regulatory Framework
12.6.3.4. China Market Estimates and Forecasts, 2018-2030 (USD Million)
12.6.4. India
12.6.4.1. Key Country Dynamics
12.6.4.2. Competitive Scenario
12.6.4.3. Regulatory Framework
12.6.4.4. India Market Estimates and Forecasts, 2018-2030 (USD Million)
12.6.5. Thailand
12.6.5.1. Key Country Dynamics
12.6.5.2. Competitive Scenario
12.6.5.3. Regulatory Framework
12.6.5.4. Thailand Market Estimates and Forecasts, 2018-2030 (USD Million)
12.6.6. South Korea
12.6.6.1. Key Country Dynamics
12.6.6.2. Competitive Scenario
12.6.6.3. Regulatory Framework
12.6.6.4. South Korea Market Estimates and Forecasts, 2018-2030 (USD Million)
12.6.7. Australia
12.6.7.1. Key Country Dynamics
12.6.7.2. Competitive Scenario
12.6.7.3. Regulatory Framework
12.6.7.4. Australia Market Estimates and Forecasts, 2018-2030 (USD Million)
12.7. Latin America
12.7.1. Latin America Market Estimates and Forecasts, 2018-2030 (USD Million)
12.7.2. Brazil
12.7.2.1. Key Country Dynamics
12.7.2.2. Competitive Scenario
12.7.2.3. Regulatory Framework
12.7.2.4. Brazil Market Estimates and Forecasts, 2018-2030 (USD Million)
12.7.3. Argentina
12.7.3.1. Key Country Dynamics
12.7.3.2. Competitive Scenario
12.7.3.3. Regulatory Framework
12.7.3.4. Argentina Market Estimates and Forecasts, 2018-2030 (USD Million)
12.8. MEA
12.8.1. MEA Market Estimates and Forecasts, 2018-2030 (USD Million)
12.8.2. South Africa
12.8.2.1. Key Country Dynamics
12.8.2.2. Competitive Scenario
12.8.2.3. Regulatory Framework
12.8.2.4. South Africa Market Estimates and Forecasts, 2018-2030 (USD Million)
12.8.3. Saudi Arabia
12.8.3.1. Key Country Dynamics
12.8.3.2. Competitive Scenario
12.8.3.3. Regulatory Framework
12.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030 (USD Million)
12.8.4. UAE
12.8.4.1. Key Country Dynamics
12.8.4.2. Competitive Scenario
12.8.4.3. Regulatory Framework
12.8.4.4. UAE Market Estimates and Forecasts, 2018-2030 (USD Million)
12.8.5. Kuwait
12.8.5.1. Key Country Dynamics
12.8.5.2. Competitive Scenario
12.8.5.3. Regulatory Framework
12.8.5.4. Kuwait Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 13. Competitive Landscape
13.1. Market Participant Categorization
13.2. Company Market Share Analysis, 2023/24
13.3. Company Profiles
13.3.1. AbbVie Contract Manufacturing
13.3.1.1. Company Overview
13.3.1.2. Financial Performance
13.3.1.3. Service Benchmarking
13.3.1.4. Strategic Initiatives
13.3.2. Almac Group
13.3.2.1. Company Overview
13.3.2.2. Financial Performance
13.3.2.3. Service Benchmarking
13.3.2.4. Strategic Initiatives
13.3.3. Boehringer Ingelheim BioXcellence
13.3.3.1. Company Overview
13.3.3.2. Financial Performance
13.3.3.3. Service Benchmarking
13.3.3.4. Strategic Initiatives
13.3.4. Catalent
13.3.4.1. Company Overview
13.3.4.2. Financial Performance
13.3.4.3. Service Benchmarking
13.3.4.4. Strategic Initiatives
13.3.5. Dr. Reddy's Laboratories
13.3.5.1. Company Overview
13.3.5.2. Financial Performance
13.3.5.3. Service Benchmarking
13.3.5.4. Strategic Initiatives
13.3.6. Fareva
13.3.6.1. Company Overview
13.3.6.2. Financial Performance
13.3.6.3. Service Benchmarking
13.3.6.4. Strategic Initiatives
13.3.7. Fujifilm Diosynth Biotechnologies
13.3.7.1. Company Overview
13.3.7.2. Financial Performance
13.3.7.3. Service Benchmarking
13.3.7.4. Strategic Initiatives
13.3.8. Jubilant HollisterStier
13.3.8.1. Company Overview
13.3.8.2. Financial Performance
13.3.8.3. Service Benchmarking
13.3.8.4. Strategic Initiatives
13.3.9. Lonza Group
13.3.9.1. Company Overview
13.3.9.2. Financial Performance
13.3.9.3. Service Benchmarking
13.3.9.4. Strategic Initiatives
13.3.10. Patheon (Thermo Fisher Scientific)
13.3.10.1. Company Overview
13.3.10.2. Financial Performance
13.3.10.3. Service Benchmarking
13.3.10.4. Strategic Initiatives
13.3.11. Pfizer CentreOne
13.3.11.1. Company Overview
13.3.11.2. Financial Performance
13.3.11.3. Service Benchmarking
13.3.11.4. Strategic Initiatives
13.3.12. Prakruti Life Science
13.3.12.1. Company Overview
13.3.12.2. Financial Performance
13.3.12.3. Service Benchmarking
13.3.12.4. Strategic Initiatives
13.3.13. Recipharm
13.3.13.1. Company Overview
13.3.13.2. Financial Performance
13.3.13.3. Service Benchmarking
13.3.13.4. Strategic Initiatives
13.3.14. Samsung Biologics
13.3.14.1. Company Overview
13.3.14.2. Financial Performance
13.3.14.3. Service Benchmarking
13.3.14.4. Strategic Initiatives
13.3.15. Siegfried Holding AG
13.3.15.1. Company Overview
13.3.15.2. Financial Performance
13.3.15.3. Service Benchmarking
13.3.15.4. Strategic Initiatives
13.3.16. Vetter Pharma
13.3.16.1. Company Overview
13.3.16.2. Financial Performance
13.3.16.3. Service Benchmarking
13.3.16.4. Strategic Initiatives
13.3.17. WuXi AppTec
13.3.17.1. Company Overview
13.3.17.2. Financial Performance
13.3.17.3. Service Benchmarking
13.3.17.4. Strategic Initiatives
List of tables
Table. 1 List of Secondary Sources
Table. 2 List of Abbreviations
Table. 3 Global Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 4 Global Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 5 Global Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 6 Global Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 7 Global Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 8 Global Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 9 Global Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 10 Global Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 11 North America Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
Table. 12 North America Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 13 North America Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 14 North America Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 15 North America Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 16 North America Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 17 North America Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 18 North America Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 19 North America Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 20 U.S. Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 21 U.S. Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 22 U.S. Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 23 U.S. Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 24 U.S. Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 25 U.S. Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 26 U.S. Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 27 U.S. Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 28 Canada Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 29 Canada Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 30 Canada Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 31 Canada Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 32 Canada Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 33 Canada Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 34 Canada Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 35 Canada Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 36 Mexico Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 37 Mexico Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 38 Mexico Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 39 Mexico Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 40 Mexico Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 41 Mexico Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 42 Mexico Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 43 Mexico Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 44 Europe Pharmaceutical Contract Manufacturing, by Country, 2018-2030 (USD Million)
Table. 45 Europe Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 46 Europe Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 47 Europe Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 48 Europe Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 49 Europe Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 50 Europe Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 51 Europe Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 52 Europe Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 53 UK Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 54 UK Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 55 UK Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 56 UK Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 57 UK Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 58 UK Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 59 UK Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 60 UK Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 61 Germany Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 62 Germany Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 63 Germany Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 64 Germany Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 65 Germany Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 66 Germany Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 67 Germany Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 68 Germany Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 69 France Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 70 France Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 71 France Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 72 France Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 73 France Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 74 France Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 75 France Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 76 France Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 77 Italy Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 78 Italy Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 79 Italy Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 80 Italy Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 81 Italy Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 82 Italy Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 83 Italy Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 84 Italy Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 85 Spain Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 86 Spain Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 87 Spain Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 88 Spain Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 89 Spain Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 90 Spain Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 91 Spain Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 92 Spain Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 93 Denmark Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 94 Denmark Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 95 Denmark Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 96 Denmark Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 97 Denmark Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 98 Denmark Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 99 Denmark Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 100 Denmark Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 101 Sweden Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 102 Sweden Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 103 Sweden Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 104 Sweden Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 105 Sweden Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 106 Sweden Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 107 Sweden Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 108 Sweden Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 109 Norway Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 110 Norway Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 111 Norway Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 112 Norway Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 113 Norway Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 114 Norway Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 115 Norway Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 116 Norway Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 117 Asia Pacific Pharmaceutical Contract Manufacturing, by Country, 2018-2030 (USD Million)
Table. 118 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 119 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 120 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 121 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 122 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 123 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 124 Asia Pacific Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 125 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 126 Japan Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 127 Japan Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 128 Japan Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 129 Japan Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 130 Japan Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 131 Japan Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 132 Japan Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 133 Japan Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 134 China Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 135 China Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 136 China Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 137 China Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 138 China Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 139 China Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 140 China Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 141 China Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 142 India Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 143 India Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 144 India Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 145 India Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 146 India Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 147 India Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 148 India Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 149 India Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 150 Thailand Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 151 Thailand Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 152 Thailand Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 153 Thailand Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 154 Thailand Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 155 Thailand Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 156 Thailand Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 157 Thailand Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 158 South Korea Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 159 South Korea Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 160 South Korea Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 161 South Korea Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 162 South Korea Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 163 South Korea Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 164 South Korea Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 165 South Korea Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 166 Australia Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 167 Australia Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 168 Australia Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 169 Australia Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 170 Australia Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 171 Australia Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 172 Australia Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 173 Australia Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 174 Latin America Pharmaceutical Contract Manufacturing, by Country, 2018-2030 (USD Million)
Table. 175 Latin America Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 176 Latin America Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 177 Latin America Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 178 Latin America Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 179 Latin America Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 180 Latin America Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 181 Latin America Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 182 Latin America Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 183 Brazil Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 184 Brazil Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 185 Brazil Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 186 Brazil Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 187 Brazil Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 188 Brazil Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 189 Brazil Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 190 Brazil Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 191 Argentina Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 192 Argentina Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 193 Argentina Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 194 Argentina Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 195 Argentina Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 196 Argentina Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 197 Argentina Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 198 Argentina Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 199 Middle East & Africa Pharmaceutical Contract Manufacturing, by Country, 2018-2030 (USD Million)
Table. 200 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 201 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 202 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 203 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 204 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 205 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 206 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 207 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 208 South Africa Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 209 South Africa Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 210 South Africa Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 211 South Africa Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 212 South Africa Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 213 South Africa Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 214 South Africa Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 215 South Africa Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 216 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 217 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 218 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 219 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 220 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 221 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 222 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 223 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 224 UAE Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 225 UAE Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 226 UAE Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 227 UAE Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 228 UAE Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 229 UAE Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 230 UAE Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 231 UAE Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 (USD Million)
Table. 232 Kuwait Pharmaceutical Contract Manufacturing Market, by Service, 2018-2030 (USD Million)
Table. 233 Kuwait Pharmaceutical Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table. 234 Kuwait Pharmaceutical Contract Manufacturing Market, by Drug, 2018-2030 (USD Million)
Table. 235 Kuwait Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018-2030 (USD Million)
Table. 236 Kuwait Pharmaceutical Contract Manufacturing Market, by Workflow, 2018-2030 (USD Million)
Table. 237 Kuwait Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
Table. 238 Kuwait Pharmaceutical Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table. 239 Kuwait Pharmaceutical Contract Manufacturing Market, by Company Size, 2018-2030 ((USD Million)
Table. 240 Financial performance
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 Pharmaceutical Contract Manufacturing Market dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Pharmaceutical Contract Manufacturing Market: Service outlook and key takeaways
Figure 20 Pharmaceutical Contract Manufacturing Market: Service movement analysis
Figure 21 API manufacturing market estimates and forecast, 2018-2030 (USD Million)
Figure 22 Finished drug product manufacturing market estimates and forecast, 2018-2030 (USD Million)
Figure 23 Oral solids market estimates and forecast, 2018-2030 (USD Million)
Figure 24 Liquids market estimates and forecast, 2018-2030 (USD Million)
Figure 25 Topical market estimates and forecast, 2018-2030 (USD Million)
Figure 26 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 27 Packaging services market estimates and forecast, 2018-2030 (USD Million)
Figure 28 Pharmaceutical Contract Manufacturing Market: Product outlook and key takeaways
Figure 29 Pharmaceutical Contract Manufacturing Market: Product movement analysis
Figure 30 Small molecule market estimates and forecast, 2018-2030 (USD Million)
Figure 31 Biologics market estimates and forecast, 2018-2030 (USD Million)
Figure 32 Monoclonal antibodies market estimates and forecast, 2018-2030 (USD Million)
Figure 33 Vaccines market estimates and forecast, 2018-2030 (USD Million)
Figure 34 Recombinant proteins market estimates and forecast, 2018-2030 (USD Million)
Figure 35 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 36 Pharmaceutical Contract Manufacturing Market: Drug outlook and key takeaways
Figure 37 Pharmaceutical Contract Manufacturing Market: Drug movement analysis
Figure 38 Generics market estimates and forecast, 2018-2030 (USD Million)
Figure 39 Branded market estimates and forecast, 2018-2030 (USD Million)
Figure 40 Pharmaceutical Contract Manufacturing Market: Scale of operation outlook and key takeaways
Figure 41 Pharmaceutical Contract Manufacturing Market: Scale of operation movement analysis
Figure 42 Batch market estimates and forecast, 2018-2030 (USD Million)
Figure 43 Continuous market estimates and forecast, 2018-2030 (USD Million)
Figure 44 Pharmaceutical Contract Manufacturing Market: Workflow outlook and key takeaways
Figure 45 Pharmaceutical Contract Manufacturing Market: Workflow movement analysis
Figure 46 Clinical market estimates and forecast, 2018-2030 (USD Million)
Figure 47 Commercial market estimates and forecast, 2018-2030 (USD Million)
Figure 48 Pharmaceutical Contract Manufacturing Market: Application outlook and key takeaways
Figure 49 Pharmaceutical Contract Manufacturing Market: Application movement analysis
Figure 50 Oncology market estimates and forecast, 2018-2030 (USD Million)
Figure 51 Infectious diseases market estimates and forecast, 2018-2030 (USD Million)
Figure 52 Neurological disorders market estimates and forecast, 2018-2030 (USD Million)
Figure 53 Cardiovascular disease market estimates and forecast, 2018-2030 (USD Million)
Figure 54 Metabolic disorders market estimates and forecast, 2018-2030 (USD Million)
Figure 55 Autoimmune diseases market estimates and forecast, 2018-2030 (USD Million)
Figure 56 Respiratory diseases market estimates and forecast, 2018-2030 (USD Million)
Figure 57 Ophthalmology market estimates and forecast, 2018-2030 (USD Million)
Figure 58 Gastrointestinal disorders market estimates and forecast, 2018-2030 (USD Million)
Figure 59 Hormonal disorders market estimates and forecast, 2018-2030 (USD Million)
Figure 60 Hematological disorders market estimates and forecast, 2018-2030 (USD Million)
Figure 61 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 62 Pharmaceutical Contract Manufacturing Market: End Use outlook and key takeaways
Figure 63 Pharmaceutical Contract Manufacturing Market: End Use movement analysis
Figure 64 Pharmaceutical companies market estimates and forecast, 2018-2030 (USD Million)
Figure 65 Biotechnology companies market estimates and forecast, 2018-2030 (USD Million)
Figure 66 Pharmaceutical Contract Manufacturing Market: Company Size outlook and key takeaways
Figure 67 Pharmaceutical Contract Manufacturing Market: Company Size movement analysis
Figure 68 Small market estimates and forecast, 2018-2030 (USD Million)
Figure 69 Medium market estimates and forecast, 2018-2030 (USD Million)
Figure 70 Large market estimates and forecast, 2018-2030 (USD Million)
Figure 71 Regional Marketplace: Key Takeaways
Figure 72 North America Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 73 Key country dynamics
Figure 74 U.S. Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 75 Key country dynamics
Figure 76 Canada Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 77 Key country dynamics
Figure 78 Mexico Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 79 Europe Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 80 Key country dynamics
Figure 81 UK Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 82 Key country dynamics
Figure 83 Germany Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 84 Key country dynamics
Figure 85 France Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 86 Key country dynamics
Figure 87 Italy Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 88 Key country dynamics
Figure 89 Spain Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 90 Key country dynamics
Figure 91 Denmark outsourcing market estimates and forecasts, 2018-2030 (USD Million)
Figure 92 Key country dynamics
Figure 93 Sweden outsourcing market estimates and forecasts, 2018-2030 (USD Million)
Figure 94 Key country dynamics
Figure 95 Norway outsourcing market estimates and forecasts, 2018-2030 (USD Million)
Figure 96 Asia Pacific Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 97 Key country dynamics
Figure 98 Japan Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 99 Key country dynamics
Figure 100 China Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 101 Key country dynamics
Figure 102 India Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 103 Key country dynamics
Figure 104 Thailand Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 105 Key country dynamics
Figure 106 South Korea Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 107 Key country dynamics
Figure 108 Australia Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 109 Latin America Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 110 Key country dynamics
Figure 111 Brazil Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 112 Key country dynamics
Figure 113 Argentina Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 114 MEA Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 115 Key country dynamics
Figure 116 South Africa Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 117 Fig. Key country dynamics
Figure 118 Saudi Arabia Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 119 Key country dynamics
Figure 120 UAE Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 121 Key country dynamics
Figure 122 Kuwait Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Figure 123 Key company categorization
Figure 124 Service heat map analysis
Figure 125 Strategic framework

Companies Mentioned

The major companies profiled in this Pharmaceutical Contract Manufacturing market report include:
  • AbbVie Contract Manufacturing
  • Almac Group
  • Boehringer Ingelheim BioXcellence
  • Catalent
  • Dr. Reddy's Laboratories
  • Fareva
  • Fujifilm Diosynth Biotechnologies
  • Jubilant HollisterStier
  • Lonza Group
  • Patheon (Thermo Fisher Scientific)
  • Pfizer CentreOne
  • Prakruti Life Science
  • Recipharm
  • Samsung Biologics
  • Siegfried Holding AG
  • Vetter Pharma
  • WuXi AppTec

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 129.19 Billion
Forecasted Market Value ( USD ) by 2030 $ 224.51 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030 - Product Image

High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030

  • Report
  • 130 Pages
  • Global
From
Fill-finish Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Prefilled Syringes, Vials, Cartridges), By Molecule (Large, Small), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Fill-finish Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Prefilled Syringes, Vials, Cartridges), By Molecule (Large, Small), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market by Service, End-User - Global Forecast 2025-2030 - Product Image

Pharmaceutical Contract Manufacturing Market by Service, End-User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Pharmaceutical Contract Development & Manufacturing Market by Service, Development Stage, End User - Global Forecast 2025-2030 - Product Image

Pharmaceutical Contract Development & Manufacturing Market by Service, Development Stage, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Europe Fill Finish Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Prefilled Syringes, Vials, Cartridges), By Molecule, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Europe Fill Finish Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Prefilled Syringes, Vials, Cartridges), By Molecule, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Europe
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.